Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEmmerson Plc Regulatory News (EML)

Share Price Information for Emmerson Plc (EML)

Share Price is delayed by 15 minutes
Get Live Data
2.075    0.075 (3.75%)
Bid:
1.95
Ask:
2.20
Spread: 0.25 (12.821%)
Market Cap: £27.73m
EML Live PriceLast checked at - London Stock Exchange

Intraday Emmerson Plc Share Chart

Interim Results

30 Sep 2025 07:00

RNS Number : 2358B
Emmerson PLC
30 September 2025
 

 

Emmerson PLC / Ticker: EML / Index: AIM / Sector: Mining

 

30 September 2025

Emmerson PLC

("Emmerson" or the "Company")

 

Interim Results for the six months ended 30 June 2025

 

Emmerson PLC is pleased to announce its Interim Results for the six month period ended 30 June 2025 and to provide a brief update on activities.

 

Highlights

· Request for Arbitration (RFA) submitted to the International Centre for Settlement of Investment Disputes (ICSID) in the period regarding the dispute with the Kingdom of Morocco in relation to the Khemisset Potash Project in Morocco (the "Project")

· Emmerson is claiming full compensation for the loss of the Project, previously valued internally at US$2.2 billion

· Litigation funding facility for up to US$11.0 million secured, sufficient to cover all expected legal costs and working capital requirements for the duration of proceedings (US$0.8 million of which was drawn down in the period)

· Cash balance at 30 June 2025 was US$0.6 million

 

Legal matters

 

On 30 April 2025, the Company's direct and indirect subsidiaries Khemisset UK Ltd. and Potasse de Khemisset S.A. (the "Claimants") filed a Request for Arbitration ("RFA") with the International Centre for Settlement of Investment Disputes ("ICSID"). The ICSID Secretary-General registered the RFA on 23 May 2025.

 

The Claimants seek compensation for the loss and damage they sustained as a result of Morocco's breaches of its obligations under the Agreement between the Government of the United Kingdom of Great Britain and Northern Ireland and the Government of the Kingdom of Morocco for the Promotion and Protection of Investments (the "BIT"), including (i) Morocco's expropriation of the Project in violation of Article 6(1) of the BIT, and (ii) Morocco's breach of its obligations to accord the Claimants fair and equitable treatment, to provide full protection and security to the Claimants and their investments, and to refrain from impairing the Claimants' investments by discriminatory measures under Article 2(2) of the BIT.

 

The Claimants will quantify the amount of compensation sought during the course of the arbitral proceedings, taking into account that the Company's most recent valuation of the Project was approximately US$ 2.2 billion.

 

On 5 August 2025, Stanimir A. Alexandrov (a Bulgarian national) accepted his appointment by the Claimants as arbitrator. On 15 August 2025, Zachary Douglas KC, a national of Australia and Switzerland, accepted his appointment by the Respondent as arbitrator. The Company anticipates that the arbitral tribunal will be constituted in or around October 2025. The Company further anticipates that the Claimants' written memorial will be due in or around Q1 2026 and will set forth in greater detail the factual and legal grounds for the Claimants' claims.

 

The Claimants will continue zealously to pursue their claims in this matter.

 

 

For further information, please visit www.emmersonplc.com, follow us on Twitter (@emmerson_plc), or contact:

 

Emmerson PLC

Graham Clarke / Hayden Locke

 

 

+44 (0) 207 138 3204

Panmure Liberum Limited (Nominated Advisor and Broker)

Scott Mathieson / Will King

 

+44 (0)20 3100 2000

 

Condensed Consolidated Statement of Comprehensive Income

for the six months ended 30 June 2025

 

US$'000

6 months to

30 Jun 2025

6 months to

30 Jun 2024

12 months to

31 Dec 2024

Notes

(Unaudited)

(Unaudited)

(Audited)

 

 

 

Administrative expenses

3

(936)

(1,496)

(4,438)

Legal expenses

4

(1,004)

-

-

Impairment

-

-

(21,103)

Share-based payment expense

(104)

(135)

(270)

Net foreign exchange gain/(loss)

33

38

(18)

Operating loss

 

(2,011)

(1,593)

(25,829)

 

 

 

 

 

Other income

4

727

-

-

Finance cost

 

(5)

(3)

(5)

Loss before tax

(1,289)

(1,596)

(25,834)

Income tax

(1)

-

64

Loss for the period attributable to equity owners

(1,290)

(1,596)

(25,770)

Other comprehensive income

Exchange (loss)/gain on translating foreign operations

(68)

8

(306)

Total comprehensive loss attributable to equity owners

 

(1,358)

(1,588)

(26,076)

 

 

Loss per share (cents)

6

(0.10)

(0.15)

(2.32)

 

 

Condensed Consolidated Statement of Financial Position at 30 June 2025

 

US$'000

30 June 2025

30 June 2024

31 Dec 2024

Notes

(Unaudited)

(Unaudited)

(Audited)

Non-current assets

 

 

 

Intangible assets

7

-

20,648

-

Property, plant and equipment

-

28

-

Total non-current assets

-

20,676

-

Current assets

Trade and other receivables

119

1,310

762

Cash and cash equivalents

573

2,392

923

Total current assets

692

3,702

1,685

Total assets

 

692

24,378

1,685

 

 

 

Non-current liabilities

 

 

Long-term liabilities

5

(354)

-

(354)

Total non-current liabilities

 

(354)

-

(354)

 

 

 

Current liabilities

Litigation fees

4

(277)

-

-

Trade and other payables

5

(361)

(290)

(472)

Total current liabilities

 

(638)

(290)

(472)

Net (liabilities)/assets

(300)

24,088

859

Shareholders equity attributable to equity owners

Share capital

38,558

36,375

34,958

Share-based payment reserve

1,307

2,507

1,202

Reverse acquisition reserve

2,234

2,234

2,234

Retained earnings

(41,810)

(16,821)

(40,520)

Translation reserve

(589)

(207)

(512)

Total equity

(300)

24,088

859

 

Condensed Consolidated Statement of Changes in Equity for the six months ended 30 June 2025

 

US$'000

Share

Capital

Share-based payment reserve

Reverse acquisition reserve

Retained earnings

Translation reserve

Total equity

Balance at 1 January 2024

34,958

1,633

2,234

(15,451)

(215)

23,159

Loss for the period

-

-

-

(1,596)

-

(1,596)

Other comprehensive loss:

FX on translating foreign operations

-

-

-

-

8

8

Total comprehensive loss

-

-

-

(1,596)

8

(1,588)

Issue of shares for cash

2,472

-

-

-

-

2,472

Warrants issued with equity

(965)

965

-

-

-

-

Share issue costs

(90)

-

-

-

-

(90)

Share option expired

-

(226)

-

226

-

-

Fair value of share options

-

135

-

-

-

135

Balance at 30 June 2024

36,375

2,507

2,234

(16,821)

(207)

24,088

 

Balance at 1 January 2025

38,464

1,202

2,234

(40,520)

(521)

859

Loss for the period

-

-

-

(1,290)

-

(1,290)

Other comprehensive gain:

FX on translating foreign operations

-

-

-

-

(68)

(68)

Total comprehensive loss

-

-

-

(1,290)

(68)

(1,358)

Shares issued to directors

106

-

-

-

-

106

Share issue costs

(12)

-

-

-

-

(12)

Fair value of share options

-

105

-

-

-

105

Balance at 30 June 2025

38,558

1,307

2,234

(41,810)

(589)

(300)

 

 

Condensed Consolidated Statement of Cash Flows for the six months ended 30 June 2025

 

6 months to

30 June 2025

6 months to

30 June 2024

12 months to

31 Dec 2024

(Unaudited)

(Unaudited)

(Audited)

US$'000

US$'000

US$'000

Cash flows from operating activities

 

 

Loss before tax

(1,290)

(1,596)

(25,834)

Adjustments:

Foreign exchange

(33)

38

18

Taxation

-

-

64

Intangible asset impairment

-

-

20,352

VAT receivable payment

-

-

751

Directors' remuneration settled in shares

106

-

90

Share-based payments

104

135

270

Depreciation

-

5

16

Changes in working capital:

Decrease/(increase) in trade and other receivables

679

(230)

212

Increase/(decrease) in trade and other payables

166

(56)

477

Net cash flows used in operating activities

(268)

(1,704)

(3,584)

 

 

 

 

 

Cash flows from investing activities

Exploration expenditure

-

(216)

(201)

Purchase of property, plant and equipment

-

(2)

-

Net cash flows used in investing activities

-

(218)

(201)

 

 

 

Cash flows from financing activities

Net (costs)/proceeds from allotment of shares

(12)

2,382

2,771

Net cash flows from financing activities

(12)

2,382

2,771

 

 

 

(Decrease)/increase in cash and cash equivalents

(280)

460

(1,014)

Cash and cash equivalents at beginning of period

923

1,937

1,937

Foreign exchange on cash and cash equivalents

(70)

(5)

-

Cash and cash equivalents at end of period

573

2,392

923

 

 

 

 

 

Notes to the Condensed Consolidated Financial Statements for the six months ended 30 June 2025

 

1. General information

Emmerson PLC (the "Company") is a company incorporated and domiciled in the Isle of Man, whose shares have since 27 April 2021 been listed on AIM.

 

The principal activities of the Group are the pursuance of a dispute with the Moroccan Government regarding the Khemisset Potash project, and the development of the Company's proprietary potash processing technology known as KMP. In previous years, the principal activity was the development of the Khemisset Potash project, however the rejection of the Company's environmental permit application in October 2024, resulting in the total expropriation of the Project, necessitated a change in strategy.

 

2. Basis of preparation

2.1 General

The Condensed Consolidated Financial Statements have been prepared in accordance with the valuation and recognition principles of UK-adopted International Accounting Standards. The Condensed Consolidated Financial Statements for the six months ended 30 June 2025 are unaudited and have not been reviewed by the Group's auditor, and do not include all of the information required for full annual financial statements.

 

They should be read in conjunction with the Company's annual financial statements for the year ended 31 December 2024. The principal accounting policies applied in the preparation of the Condensed Consolidated Financial Statements are unchanged from those disclosed in those statements. These policies have been consistently applied to each of the periods presented.

 

The financial information of the Group is presented in US Dollars, which is also the functional currency of the parent Company and has been prepared under the historical cost convention. The individual financial statements of each of the Company's wholly owned subsidiaries are prepared in the currency of the primary economic environment in which it operates (its functional currency).

 

2.2 Basis of consolidation

The Consolidated Financial Statements comprise the financial statements of the Company, Moroccan Salts Limited ("MSL"), Potasse de Khemisset SA, Mines de Centre SARL, and Khemisset UK Ltd ("KUL").

 

Subsidiaries are fully consolidated from the date of acquisition, being the date on which the Group obtains control. Control is achieved when the Group is exposed, or has rights, to variable returns from its involvement with the investee and has the ability to affect those returns through its power over the investee.

 

Generally, there is a presumption that a majority of voting rights result in control. To support this presumption and when the Group has less than a majority of the voting or similar rights of an investee, the Group considers all relevant facts and circumstances in assessing whether it has power over an investee, including:

 

· The contractual arrangement with the other vote holders of the investee;

· Rights arising from other contractual arrangements; and

· The Group's voting rights and potential voting rights.

 

The Group re-assesses whether or not it controls an investee if facts and circumstances indicate that there are changes to one or more of the three elements of control. Subsidiaries are fully consolidated from the date on which control is transferred to the Group. They are deconsolidated from the date that control ceases. Assets, liabilities, income and expenses of a subsidiary acquired or disposed of during the period are included in the Group Financial Statements from the date the Group gains control until the date the Group ceases to control the subsidiary.

 

All intra-group balances, transactions, income and expenses and profits and losses resulting from intra-group transactions that are recognised in assets, are eliminated in full.

 

All the Group's companies have 31 December as their year-end. Consolidated financial statements are prepared using uniform accounting policies for like transactions.

 

2.3 Functional and presentational currencyThe financial information of the Group is presented in US Dollars, which is also the functional currency of the parent Company, and has been prepared under the historical cost convention. The individual financial statements of each of the Company's wholly owned subsidiaries are prepared in the currency of the primary economic environment in which it operates (its functional currency).

 

2.4 Going concern

As at 18 September 2025 the Group had cash and cash equivalents of US$1.1 million. On 2 January 2025, the Company signed a Capital Provision Agreement ("CPA") with a specialist litigation funding firm to provide up to US$11.0 million in both litigation finance capital and working capital for the Company.

 

The Company has prepared a cashflow forecast to December 2026 setting out the expected financial commitments related to the running of the Group in its reduced scale, and the legal and other advisory expenses related to the ongoing dispute with the Moroccan government. The Company will not commit to further material financial obligations for at least the 12 months from the date of this report in order to protect its Going Concern position.

 

Based on a review of the cashflow forecast, the Board is satisfied that the existing cash and funding facility are more than sufficient to meet the Company's outgoings for at least 12 months from the date of this report, and therefore believe the Going Concern basis is appropriate for the preparation of the financial statements.

 

3. Administrative fee and other expenses

US$'000

6 months to

30 Jun 2025

6 months to

30 Jun 2024

12 months to

31 Dec 2024

(Unaudited)

(Unaudited)

(Audited)

Directors' fees

380

296

599

Depreciation

-

5

16

Travel and accommodation

3

6

2

Auditors' remuneration

18

37

63

Employment costs

19

425

702

Professional and consultancy fees

289

565

1,055

Other expenses

227

162

2,001

Total Administrative Expenses

936

1,496

4,438

 

4. Litigation funding

On 2 January 2025, the Company announced that it had signed a Capital Provision Agreement ("CPA") with a specialist litigation funding firm to provide up to US$11.0 million in both litigation finance capital and working capital for the Company (the "Funding"). Funds advanced under the CPA can be used to settle legal fees connected with the case, as well as for general working capital purposes, subject to approvals.

 

Funds advanced are non-recourse and are not repayable in the event of the legal case being lost. If the case has a successful outcome, the litigation funding firm will receive capital a capital entitlement based on multiples of the amounts advanced, or a percentage of the total settlement, depending on the timing and quantum of the settlement.

 

Because the funds advanced confer present benefits whose value can be quantified, these advances are recognised as Other Income. The balance of entitlements under the CPA will be recognised upon settlement of the legal case, as a reduction against the final award.

 

During the period, the Company incurred litigation expenses of US$1,004k, of which US$727k were settled through advances and has been recognised as Other Income. The balance of US$277k has been recorded as a Current Liability.

 

5. Current and Non-current liabilities

On 30 April 2025, the Company reached a legal settlement agreement related to a contract dated 29 November 2021 relating to the provision of basic engineering package for the Company's Khemisset Potash Project. The settlement amount agreed between both parties is US$427k, payable in 3 instalments with the final payment due on 27 May 2027. This amount has been split between current and non-current liabilities accordingly.

 

6. Earnings per share

The calculation of the basic and diluted earnings per share is based on the following data:

 

US$'000

6 months to

30 Jun 2025

6 months to

30 Jun 2024

12 months to

31 Dec 2024

 

(Unaudited)

(Unaudited)

(Audited)

 

Earnings

 

Loss from continuing operations for the period attributable to the equity holders of the Company

(1,290)

(1,596)

(25,770)

Number of shares

Weighted average number of ordinary shares for the purpose of basic and diluted earnings per share

1,293,070,615

1,052,292,157

1,111,428,463

Basic and diluted loss per share

0.10 cents

0.15 cents

2,32 cents

 

 

7. Intangible assets

The intangible assets consist of capitalised exploration and evaluation expenditure, including the cost of acquiring the mining license and research permits held by the Company's subsidiaries.

 

30 Jun 2025

30 Jun 2024

31 Dec 2024

(Unaudited)

(Unaudited)

(Audited)

US$'000

US$'000

US$'000

Cost:

 

 

 

At the beginning of the period

-

20,457

20,457

Additions

-

216

201

-

(20,353)

Exchange differences

-

(25)

(305)

As at end of period

-

20,648

-

 

During the period ended 31 December 2024, the Company fully impaired the capitalised exploration and evaluation costs in respect of the Khemisset project, following the rejection of the ESIA in October 2024.

 

8. Related party transactions

Directors' consultancy fees

Graham Clarke is a Director of the Company and also provides consulting services to the Company. During the period, Graham Clarke received fees of US$150k (H1 2024: nil). The amount outstanding as at the period end was US$ nil (31 Dec 2024: US$ nil).

 

Robert Wrixon is a Director of the Company and also provides consulting services to the Company. During the period, Robert Wrixon received fees of US$30k (H1 2024: US$15k). The amount outstanding as at the period end was US$ nil (31 Dec 2024: US$ nil).

 

Hayden Locke is a Director of the Company and also provides consulting services to the Company. During the period, Hayden Locke received fees of US$40k (2024: US$nil). The amount outstanding as at the period end was US$ nil (31 Dec 2024: US$ nil).

 

9. Post-balance sheet events

There were no post-balance sheet events.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GZGZLMLLGKZM
Date   Source Headline
15th Apr 20197:00 amRNSHeads of Agreement Signed for 100% Offtake
8th Apr 20199:15 amRNSLaunch of Company Quarterly Newsletter
1st Apr 20197:00 amRNSCommencement of Metallurgical Testing
27th Mar 201911:40 amRNSResearch Note published by Shard Capital Partners
18th Mar 201912:00 pmRNSFree Investor Class Ticket to the UK Investor Show
18th Mar 20197:00 amRNSCompletion of Environmental Baseline Study
13th Mar 20197:00 amRNSUpcoming Investor Events
4th Mar 20193:21 pmRNSReplacement: Potential Capex Savings at Port
4th Mar 20199:05 amRNSSecond Price Monitoring Extn
4th Mar 20199:00 amRNSPrice Monitoring Extension
4th Mar 20197:00 amRNSPotential Further Capex Savings at Port
20th Feb 20197:00 amRNSAppointment of Metallurgy and Process Consultant
13th Feb 20197:00 amRNSLondon Investor Event
12th Feb 20197:00 amRNSCommencement of ESIA Baseline Studies
4th Feb 20193:14 pmRNSDirector/PDMR Shareholding
28th Jan 20197:00 amRNSDirector/PDMR Shareholding
17th Jan 20197:00 amRNSInvestor Event in Birmingham
15th Jan 20197:00 amRNSCorporate Update
28th Dec 20184:41 pmRNSSecond Price Monitoring Extn
28th Dec 20184:36 pmRNSPrice Monitoring Extension
26th Nov 201811:00 amRNSShareholder and Analyst Call Recording
22nd Nov 201811:05 amRNSUpdate re Shareholder and Analyst Call at 11am
22nd Nov 20188:38 amRNSPublication of Research Note
20th Nov 20187:00 amRNSLow Capex Potential Confirmed by Scoping Study
12th Nov 20187:00 amRNSPotential for Very Low Capital Cost Port Upgrade
5th Nov 201811:00 amRNSDrilling Commences at Khemisset Potash Project
23rd Oct 20187:00 amRNSCost Estimate for Electrical and Gas Supply
8th Oct 20187:00 amRNSVery Low Capital Cost Logistics Solution Potential
2nd Oct 20183:14 pmRNSDirector/PDMR Shareholding
28th Sep 20187:00 amRNSInterim Results
18th Sep 20187:00 amRNSKhemisset Project:Decline Design and Cost Estimate
6th Sep 20187:00 amRNSSeismic Interpretation and Operations Update
4th Sep 20187:00 amRNSInitiation of Research Coverage
31st Aug 20188:15 amRNSInvestor Event
15th Aug 20187:00 amRNSExploration Target Indicates Large-Scale Potential
13th Aug 20182:30 pmRNSSuccessful Stakeholder Day at Khemisset Project
8th Aug 20187:00 amRNSGrant of Additional Research Permits at Khemisset
27th Jul 201812:29 pmRNSResult of AGM
10th Jul 20187:00 amRNSCompletion of Seismic Survey at Khemisset Project
3rd Jul 20189:19 amRNSNotice of AGM
2nd Jul 20187:00 amRNSAppointment of Mining Industry Veteran as Chairman
13th Jun 20187:00 amRNSAppointment of Khemisset Scoping Study Consultant
6th Jun 20183:15 pmRNSCorporate Presentation and Handout
4th Jun 20182:05 pmRNSSecond Price Monitoring Extn
4th Jun 20182:00 pmRNSPrice Monitoring Extension
4th Jun 20187:00 amRNSRe-Admission to the London Stock Exchange
1st Jun 201812:15 pmRNSResults of General Meeting - Replacement
1st Jun 201810:30 amRNSResult of General Meeting
9th May 20185:22 pmRNSPublication of Prospectus and Notice of GM
30th Apr 20183:28 pmRNSReport and Financial Statements

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.